SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-006968
Filing Date
2020-03-20
Accepted
2020-03-20 16:07:07
Documents
4
Period of Report
2020-03-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea119784-8k_soligenix.htm 8-K 32587
2 OPINION OF DUANE MORRIS LLP ea119784ex5-1_soligenix.htm EX-5.1 27826
3 GRAPHIC ex5-1_001.jpg GRAPHIC 6622
4 GRAPHIC ex5-1_002.jpg GRAPHIC 5136
  Complete submission text file 0001213900-20-006968.txt   78258
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 20732056
SIC: 2834 Pharmaceutical Preparations